ticlopidine has been researched along with Cardiac Remodeling, Ventricular in 4 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "All ticagrelor treatments improved left ventricular ejection fraction, acute (69." | 5.42 | Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction. ( Birnbaum, GD; Birnbaum, Y; Nanhwan, MK; Nylander, S; Perez-Polo, JR; Ye, Y, 2015) |
| "The objective of this study is to investigate the interaction of Panax quinquefolius saponin (PQS) and dual antiplatelets (aspirin and clopidogrel) on antiplatelet activity and vascular endothelial function in rats with acute myocardial infarction (AMI)." | 3.81 | Interaction of Panax quinquefolius Saponin and Dual Antiplatelets on Vascular Endothelial Function in Rats with Acute Myocardial Infarction. ( Liu, J; Liu, Y; Shang, Q; Shi, D; Wang, B; Zhang, L; Zhang, Q, 2015) |
| "All ticagrelor treatments improved left ventricular ejection fraction, acute (69." | 1.42 | Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction. ( Birnbaum, GD; Birnbaum, Y; Nanhwan, MK; Nylander, S; Perez-Polo, JR; Ye, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fonseca, FAH | 1 |
| Izar, MC | 1 |
| Maugeri, IML | 1 |
| Berwanger, O | 1 |
| Damiani, LP | 1 |
| Pinto, IM | 1 |
| Szarf, G | 1 |
| França, CN | 1 |
| Bianco, HT | 1 |
| Moreira, FT | 1 |
| Caixeta, A | 1 |
| Alves, CMR | 1 |
| Soriano Lopes, A | 1 |
| Klassen, A | 1 |
| Tavares, MFM | 1 |
| Fonseca, HA | 1 |
| Carvalho, ACC | 1 |
| Ye, Y | 1 |
| Birnbaum, GD | 1 |
| Perez-Polo, JR | 1 |
| Nanhwan, MK | 1 |
| Nylander, S | 1 |
| Birnbaum, Y | 1 |
| Wang, B | 1 |
| Liu, Y | 1 |
| Shang, Q | 1 |
| Zhang, Q | 1 |
| Zhang, L | 1 |
| Liu, J | 1 |
| Shi, D | 1 |
| Park, Y | 1 |
| Tantry, US | 1 |
| Koh, JS | 1 |
| Ahn, JH | 1 |
| Kang, MG | 1 |
| Kim, KH | 1 |
| Jang, JY | 1 |
| Park, HW | 1 |
| Park, JR | 1 |
| Hwang, SJ | 1 |
| Park, KS | 1 |
| Kwak, CH | 1 |
| Hwang, JY | 1 |
| Gurbel, PA | 1 |
| Jeong, YH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Role of Innate and Adaptive Immunity After Acute Myocardial Infarction BATTLE-AMI Study (B And T Types of Lymphocytes Evaluation in Acute Myocardial Infarction)[NCT02428374] | Phase 4 | 300 participants (Anticipated) | Interventional | 2015-05-31 | Recruiting | ||
| WilL LOWer Dose Aspirin be More Effective Following ACS? (WILLOW-ACS)[NCT02741817] | Phase 4 | 20 participants (Actual) | Interventional | 2016-06-26 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for ticlopidine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Effects of four antiplatelet/statin combined strategies on immune and inflammatory responses in patients with acute myocardial infarction undergoing pharmacoinvasive strategy: Design and rationale of the B and T Types of Lymphocytes Evaluation in Acute My
Topics: Adenosine; Anti-Inflammatory Agents; B-Lymphocytes; Biomarkers; Brazil; Clinical Protocols; Clopidog | 2017 |
3 other studies available for ticlopidine and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Ticagrelor protects the heart against reperfusion injury and improves remodeling after myocardial infarction.
Topics: Adenosine; Administration, Oral; Animals; Apoptosis; Cardiotonic Agents; Clopidogrel; Disease Models | 2015 |
Interaction of Panax quinquefolius Saponin and Dual Antiplatelets on Vascular Endothelial Function in Rats with Acute Myocardial Infarction.
Topics: Animals; Aspirin; Clopidogrel; Coronary Vessels; Endothelial Cells; Humans; Male; Myocardial Infarct | 2015 |
Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
Topics: Aged; Aspirin; Biomarkers; Blood Platelets; C-Reactive Protein; Chi-Square Distribution; Clopidogrel | 2017 |